5 Form 4 filings for RANI between 2026-07-21 and 2026-08-04, from 4 filers. 4 discretionary (1 sales, 1 purchases), 1 routine grant or withholding filing. 1 of 5 state a filing-level total, summing to $301; the rest report only their largest transaction, so the true figure is higher. Prices ran $1 to $1.
| Filed | Filer | Role | Action | Shares largest txn | Price | Filing total | Txns |
|---|---|---|---|---|---|---|---|
| 2026-08-04 | Gilson Michelle (Director at Rani Therapeutics Holdings, Inc.) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 2026-07-21 | Javadi Alireza | Chief Technical Officer | sold | 386 | $0.78 | $301 | 2 |
| 2026-07-21 | Imran Talat | purchased | 35,000 | $0.72 | — | — | |
| 2026-07-21 | Imran Talat | — | 9,099 | $0.81 | — | 7 | |
| 2026-07-21 | Maestas Nicholas (Chief Financial Officer at Rani Therapeutics Holdings, Inc.) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 5 filings · 4 filers · disclosed totals only | $301 (1/5) | — | |||||